{"transactions":[{"id":3465180,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"Options to purchase Common Stock","published_at":"2019-07-09T20:01:43.000Z","date":"2019-04-17","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options granted were fully vested on June 4, 2016. This grant was reinstated by the Issuer's Board of Directors on April 17, 2019."}],"balance_after":200000,"derivative":{"exercise_price":9.21,"expiration_date":"2023-06-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-19-034107","document":"tv524928_form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420419034107/tv524928_form4a.xml","form_type":"4/A","original_submission_date":"2018-12-13"}},{"id":3465179,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2019-07-09T20:01:43.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"400,000 shares of the Issuer's common stock owned by the Reporting Person vested on December 11, 2018, triggering the sale of 97,325 shares of the Issuer's common stock as reported on the Form 4, filed on December 13, 2018 (the \"Original Form 4\"). The 400,000 shares of the Issuer's common stock were inadvertently omitted from the Original Form 4."}],"balance_after":655170,"source":{"system":"sec-edgar","filing":"0001144204-19-034107","document":"tv524928_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420419034107/tv524928_form4a.xml","form_type":"4/A","original_submission_date":"2018-12-13"}},{"id":3732046,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2018-12-13T23:10:37.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":97325,"price":1.05,"value":102191.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person had no discretion with respect to such sale, which was conducted automatically by the Issuer's administrator in order to satisfy the reporting person's tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 11, 2018, was $1.03 to $1.10. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":255170,"source":{"system":"sec-edgar","filing":"0001144204-18-064511","document":"tv509132_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420418064511/tv509132_form4.xml","form_type":"4"}},{"id":4128538,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2017-12-18T23:46:51.000Z","date":"2017-12-14","kind":"sale","acquired":false,"shares":12000,"price":3.55,"value":42600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 14, 2017, was $3.53 to $3.68. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":352495,"source":{"system":"sec-edgar","filing":"0001144204-17-064182","document":"tv481629_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420417064182/tv481629_form4.xml","form_type":"4"}},{"id":4131619,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2017-12-15T01:18:08.000Z","date":"2017-12-13","kind":"sale","acquired":false,"shares":19000,"price":3.57,"value":67830.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 12, 2017, was $3.53 to $3.72, and the range of prices for the sale transactions on December 13, 2017, was $3.55 to $3.63. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":364495,"source":{"system":"sec-edgar","filing":"0001144204-17-063792","document":"tv481449_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420417063792/tv481449_form4.xml","form_type":"4"}},{"id":4131618,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2017-12-15T01:18:08.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":25593,"price":3.59,"value":91878.87,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on December 12, 2017, was $3.53 to $3.72, and the range of prices for the sale transactions on December 13, 2017, was $3.55 to $3.63. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":383495,"source":{"system":"sec-edgar","filing":"0001144204-17-063792","document":"tv481449_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420417063792/tv481449_form4.xml","form_type":"4"}},{"id":4131617,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, BIOLOGICS OPERATIONS"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2017-12-15T01:18:08.000Z","date":"2017-11-29","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued to the Reporting Person upon the partial vesting of an award of restricted stock units initially made on July 15, 2015."}],"balance_after":409088,"source":{"system":"sec-edgar","filing":"0001144204-17-063792","document":"tv481449_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000114420417063792/tv481449_form4.xml","form_type":"4"}},{"id":4599926,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Biologics Operations"}}],"security":"Common Stock, par value $0.001","published_at":"2016-09-19T20:23:52.000Z","date":"2016-09-16","kind":"sale","acquired":false,"shares":33912,"price":2.55,"value":86475.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades ranging from $2.53 to $2.62. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":259088,"source":{"system":"sec-edgar","filing":"0001638599-16-001415","document":"doc4_4237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859916001415/doc4_4237.xml","form_type":"4"}},{"id":4599925,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Biologics Operations"}}],"security":"Common Stock, par value $0.001","published_at":"2016-09-19T20:23:52.000Z","date":"2016-09-15","kind":"sale","acquired":false,"shares":15000,"price":2.54,"value":38100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades ranging from $2.49 to $2.58. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":293000,"source":{"system":"sec-edgar","filing":"0001638599-16-001415","document":"doc4_4237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859916001415/doc4_4237.xml","form_type":"4"}},{"id":4601463,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":156096,"kind":"person","name":"Avgerinos George","position":1,"cik":"0001578699","reported_name":"Avgerinos George","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Biologics Operations"}}],"security":"Common Stock, par value $0.001","published_at":"2016-09-16T20:08:28.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued to the Reporting Person upon the partial vesting of an award of restricted stock units initially made on July 15, 2015."}],"balance_after":308000,"source":{"system":"sec-edgar","filing":"0001638599-16-001407","document":"doc4_4232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1429260/000163859916001407/doc4_4232.xml","form_type":"4"}}]}